DE2304708A1 - Verfahren zur herstellung von piperazin-derivaten - Google Patents
Verfahren zur herstellung von piperazin-derivatenInfo
- Publication number
- DE2304708A1 DE2304708A1 DE2304708A DE2304708A DE2304708A1 DE 2304708 A1 DE2304708 A1 DE 2304708A1 DE 2304708 A DE2304708 A DE 2304708A DE 2304708 A DE2304708 A DE 2304708A DE 2304708 A1 DE2304708 A1 DE 2304708A1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- general formula
- compound
- general
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title description 2
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- -1 Phosphorus halides Chemical class 0.000 claims description 7
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 5
- 239000012442 inert solvent Substances 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical group 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 150000003460 sulfonic acids Chemical class 0.000 claims description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- 101100189168 Capsicum frutescens PAMT gene Proteins 0.000 claims 1
- 238000005967 Finkelstein reaction Methods 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- GPWHDDKQSYOYBF-UHFFFAOYSA-N ac1l2u0q Chemical compound Br[Br-]Br GPWHDDKQSYOYBF-UHFFFAOYSA-N 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 201000009030 Carcinoma Diseases 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 125000006016 2-bromoethoxy group Chemical group 0.000 description 1
- 125000006012 2-chloroethoxy group Chemical group 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 240000002329 Inga feuillei Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- MSQACBWWAIBWIC-UHFFFAOYSA-N hydron;piperazine;chloride Chemical compound Cl.C1CNCCN1 MSQACBWWAIBWIC-UHFFFAOYSA-N 0.000 description 1
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
- 229960000930 hydroxyzine Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N p-toluenesulfonyl chloride Substances CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- 229960002195 perazine Drugs 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH142072A CH571004A5 (enrdf_load_stackoverflow) | 1972-02-01 | 1972-02-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2304708A1 true DE2304708A1 (de) | 1973-08-23 |
Family
ID=4210035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2304708A Pending DE2304708A1 (de) | 1972-02-01 | 1973-01-31 | Verfahren zur herstellung von piperazin-derivaten |
Country Status (14)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2341110A1 (de) * | 1973-08-14 | 1975-02-27 | Crc Ricerca Chim | Verfahren zur herstellung von piperazinderivaten |
| DE2938557A1 (de) * | 1979-09-24 | 1981-04-23 | Isartaler Schraubenkompressoren Gmbh, 8192 Gertsried | Verdichteranlage |
| DK154078C (da) * | 1981-02-06 | 1989-05-22 | Ucb Sa | Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf |
| JPS57134381U (enrdf_load_stackoverflow) * | 1981-02-17 | 1982-08-21 |
-
0
- BE BE794804D patent/BE794804A/xx unknown
-
1972
- 1972-02-01 CH CH142072A patent/CH571004A5/xx not_active IP Right Cessation
-
1973
- 1973-01-26 AT AT69973*#A patent/AT331250B/de not_active IP Right Cessation
- 1973-01-29 NO NO353/73A patent/NO138090C/no unknown
- 1973-01-30 HU HUCA342A patent/HU168740B/hu unknown
- 1973-01-31 DE DE2304708A patent/DE2304708A1/de active Pending
- 1973-01-31 IL IL41440A patent/IL41440A/en unknown
- 1973-01-31 CA CA162,943A patent/CA994772A/en not_active Expired
- 1973-01-31 ES ES411147A patent/ES411147A1/es not_active Expired
- 1973-02-01 ZA ZA730730A patent/ZA73730B/xx unknown
- 1973-02-01 JP JP1333973A patent/JPS5343511B2/ja not_active Expired
- 1973-02-01 FR FR7303599A patent/FR2173982B1/fr not_active Expired
- 1973-02-01 GB GB507673A patent/GB1424611A/en not_active Expired
- 1973-02-01 NL NL7301488A patent/NL7301488A/xx not_active Application Discontinuation
-
1974
- 1974-07-31 ZA ZA00744892A patent/ZA744892B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL41440A0 (en) | 1973-03-30 |
| NO138090B (no) | 1978-03-20 |
| NL7301488A (enrdf_load_stackoverflow) | 1973-08-03 |
| AT331250B (de) | 1976-08-10 |
| CH571004A5 (enrdf_load_stackoverflow) | 1975-12-31 |
| BE794804A (fr) | 1973-05-16 |
| NO138090C (no) | 1978-06-28 |
| HU168740B (enrdf_load_stackoverflow) | 1976-07-28 |
| FR2173982A1 (enrdf_load_stackoverflow) | 1973-10-12 |
| ZA744892B (en) | 1975-08-27 |
| JPS4881879A (enrdf_load_stackoverflow) | 1973-11-01 |
| CA994772A (en) | 1976-08-10 |
| ATA69973A (de) | 1975-11-15 |
| GB1424611A (en) | 1976-02-11 |
| IL41440A (en) | 1976-05-31 |
| JPS5343511B2 (enrdf_load_stackoverflow) | 1978-11-20 |
| FR2173982B1 (enrdf_load_stackoverflow) | 1978-03-24 |
| ES411147A1 (es) | 1975-12-01 |
| ZA73730B (en) | 1974-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1670849B2 (de) | Verfahren zur herstellung von 8-acylamino-1,2,3,4-tetrahydroisochinolinen | |
| DE1770956A1 (de) | Aminoester der 2-substituierten Pentionischen Saeure (Pentinoic acid) mit antispastischer und geschwuerheilender Wirkung,deren Derivate und Verfahren zu deren Herstellung | |
| EP0071935B1 (de) | 1-Phenyl-2-aminocarbonylindol-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2304708A1 (de) | Verfahren zur herstellung von piperazin-derivaten | |
| DE2147023A1 (de) | Verfahren zur herstellung von 1htetrazol-verbindungen | |
| DE2651969C3 (de) | Verfahren zur Verarbeitung photographischer Silberfarbbleichmaterialien und dafür geeignete Zubereitungen | |
| EP0054513B1 (de) | Verfahren zur Herstellung photographischer Farbbilder nach dem Silberfarbbleichverfahren und das in diesem Verfahren verwendete photographische Material | |
| DE1033200B (de) | Verfahren zur Herstellung von N-substituierten Amidophosphorsaeuredialkylestern | |
| DE2521966C3 (de) | 33-Bis-(4-hydroxyphenyl)-7-methyl-2-indolinon-Derivate, deren Salze und Verfahren zu deren Herstellung | |
| DE2545329A1 (de) | 1-amid-alkyl-4-sulfonyl-piperazin-derivate | |
| DE2412854A1 (de) | Verfahren zur herstellung von pyrimidinen | |
| DE1518271A1 (de) | Verfahren zur Herstellung von substituierten Benzamiden | |
| DE2247893A1 (de) | Supersensibilisiertes photographisches material | |
| DE1493994A1 (de) | Verfahren zur Herstellung von Phenoxyessigsaeureverbindungen | |
| DE653307C (de) | Verfahren zur Darstellung halogenierter Piperidinabkoemmlinge | |
| DE499826C (de) | Verfahren zur Darstellung von N-Dialkylaminoalkylderivaten aromatischer Aminooxy- und Diaminoverbindungen | |
| DE1670583A1 (de) | Neue Piperidinderivate | |
| DE2230302C3 (de) | 6,6'-Methylenbfsbenzopyryliumperchlorate und Verfahren zu ihrer Herstellung sowie deren Verwendung als Sensibilisator | |
| DE515092C (de) | Verfahren zur Darstellung von Salzen des Cholins | |
| DE2759468A1 (de) | Acridinonverbindungen und ihre herstellung | |
| DE2063227B2 (de) | Elektrophotographisches Aufzeichnungsmaterial | |
| DE2028601A1 (de) | Verfahren zur Herstellung farbenphotographischer Bilder durch Farbentwicklung und farbenphotographisches Mehrschichtenmaterial | |
| DE2366296C2 (de) | Poly-N-vinyldiphenylamine | |
| DE1036639B (de) | Verfahren zur Herstellung photographischer Farbenbilder durch Entwicklung eines reduzierbaren Silbersalzes mittels einer aromatischen Amino-Entwicklersubstanz in Anwesenheit eines Farbstoffbildners | |
| AT213896B (de) | Verfahren zur Herstellung von neuen, basisch substituierten Thioäthern von Pyrimidinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHN | Withdrawal |